Literature DB >> 10926591

Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys.

M J Jarvis1, E Goddard, V Higgins, C Feyerabend, A Bryant, D G Cook.   

Abstract

OBJECTIVE: To determine whether children's exposure to passive smoking has changed since the late 1980s.
DESIGN: Cross sectional surveys of nationally representative samples of secondary school children carried out between 1988 and 1998 by Office for National Statistics.
SETTING: England.
SUBJECTS: Secondary school children aged 11-15. MAIN OUTCOME MEASURES: Salivary cotinine concentrations in non-smoking children.
RESULTS: Cotinine concentrations in all non-smoking children almost halved between 1988 and 1998, from a geometric mean of 0.96 (95% confidence interval 0.83 to 1.11) ng/ml in 1988 to 0.52 (0.43 to 0.62) ng/ml in 1998. This reduction was largely due to reductions in exposure in children from non-smoking households and to decreases in the percentage of parents who smoked. Children living with mothers or fathers who smoked experienced little reduction in exposure.
CONCLUSIONS: Exposure to passive smoking among children in England has approximately halved since the late 1980s. This reduction is partly explained by the fall in the percentage of both mothers and fathers who smoke and is also likely to reflect reductions of smoking in public places. However, there is only limited evidence that children from smoking households have experienced a reduction in exposure through parents' avoidance of smoking in their presence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926591      PMCID: PMC27450          DOI: 10.1136/bmj.321.7257.343

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Factors determining exposure to passive smoking in young adults living at home: quantitative analysis using saliva cotinine concentrations.

Authors:  M J Jarvis; A D McNeill; A Bryant; M A Russell
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

2.  Smoking behaviour in young families. Do parents take practical measures to prevent passive smoking by the children?

Authors:  W Eriksen; D Bruusgaard
Journal:  Scand J Prim Health Care       Date:  1995-12       Impact factor: 2.581

3.  Trends in environmental tobacco smoke restrictions in the home in Victoria, Australia.

Authors:  R Borland; R Mullins; L Trotter; V White
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

4.  A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids.

Authors:  C Feyerabend; M A Russell
Journal:  J Pharm Pharmacol       Date:  1990-06       Impact factor: 3.765

5.  State-specific prevalence of cigarette smoking among adults, and children's and adolescents' exposure to environmental tobacco smoke -- United States, 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-11-07       Impact factor: 17.586

6.  Saliva cotinine as an indicator of cigarette smoking in adolescents.

Authors:  A D McNeill; M J Jarvis; R West; M A Russell; A Bryant
Journal:  Br J Addict       Date:  1987-12

Review 7.  Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research.

Authors:  D G Cook; D P Strachan
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

8.  What are the determinants of children's exposure to environmental tobacco smoke at home?

Authors:  N Jaakkola; R Ruotsalainen; J J Jaakkola
Journal:  Scand J Soc Med       Date:  1994-06

9.  Determinants of passive smoking in children in Edinburgh, Scotland.

Authors:  M J Jarvis; D P Strachan; C Feyerabend
Journal:  Am J Public Health       Date:  1992-09       Impact factor: 9.308

  9 in total
  36 in total

1.  Protecting children from passive smoking.

Authors:  R Ferrence; M J Ashley
Journal:  BMJ       Date:  2000-08-05

2.  Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners.

Authors:  M J Jarvis; C Feyerabend; A Bryant; B Hedges; P Primatesta
Journal:  Tob Control       Date:  2001-12       Impact factor: 7.552

3.  Relationships between cotinine, lower respiratory tract infection, and eosinophil cationic protein in children.

Authors:  Pembe Keskinoglu; Dilek Cimrin; Gazanfer Aksakoglu
Journal:  Eur J Pediatr       Date:  2006-09-15       Impact factor: 3.183

Review 4.  Biomarkers in paediatric research and practice.

Authors:  B P Lanphear; C F Bearer
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

5.  Changes in exposure of adult non-smokers to secondhand smoke after implementation of smoke-free legislation in Scotland: national cross sectional survey.

Authors:  Sally J Haw; Laurence Gruer
Journal:  BMJ       Date:  2007-09-09

Review 6.  Population level policy options for increasing the prevalence of smokefree homes.

Authors:  George Thomson; Nick Wilson; Philippa Howden-Chapman
Journal:  J Epidemiol Community Health       Date:  2006-04       Impact factor: 3.710

7.  The impact of smokefree legislation in Scotland: results from the Scottish ITC: Scotland/UK longitudinal surveys.

Authors:  Andrew Hyland; Louise M Hassan; Cheryl Higbee; Christian Boudreau; Geoffrey T Fong; Ron Borland; K Michael Cummings; Mi Yan; Mary E Thompson; Gerard Hastings
Journal:  Eur J Public Health       Date:  2009-01-16       Impact factor: 3.367

8.  Estimate of deaths attributable to passive smoking among UK adults: database analysis.

Authors:  Konrad Jamrozik
Journal:  BMJ       Date:  2005-03-01

9.  Pediatric Secondhand Smoke Exposure: Moving Toward Systematic Multi-Level Strategies to Improve Health.

Authors:  Bradley N Collins; Jennifer Ibrahim
Journal:  Glob Heart       Date:  2012-07

10.  Changes in child exposure to environmental tobacco smoke (CHETS) study after implementation of smoke-free legislation in Scotland: national cross sectional survey.

Authors:  Patricia C Akhtar; Dorothy B Currie; Candace E Currie; Sally J Haw
Journal:  BMJ       Date:  2007-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.